NEW YORK, May 4 (GenomeWeb News) - HTG today said that Merck has licensed its ArrayPlate qNPA (quantitative nuclease protection assay) technology for its drug discovery research.

ArrayPlate qNPA offers multiplexed measurement of 16 mRNA species in each well of a standard 96-well microplate, HTG said.

HTG did not provide financial details of the licensing agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.